Chrome Extension
WeChat Mini Program
Use on ChatGLM

Phase Ib Dose-Escalation Trial of Taselisib (GDC-0032) in Combination with HER2-directed Therapies in Patients with Advanced HER2+ Breast Cancer

A. Grinshpun, S. Ren, N. Graham,M. K. Demeo, E. Wrabel, J. Carter,N. Tayob, A. Pereslete,E. Hamilton, D. Juric,E. L. Mayer,S. M. Tolaney,I. E. Krop,O. Metzger

ESMO Open(2024)

Cited 0|Views10
Key words
HER2,metastatic breast cancer,PIK3CA,taselisib,ctDNA
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined